Another study (Cheng et al., 2019) analyzing differentially expressed genes in pancreatic cancer also detected SLC6A14 among the top ten upregulated genes and survival analysis of seven of these genes (TMPRSS4, SERPINB5, SCEL SCL6A14, TMC7, SLC2A1, CENPF) is associated with patient poor prognosis. This evidence concerns the gene SLC6A14 and familial pancreatic carcinoma.